Kior sold 10 million shares below its $19 to $21 per share range and two of its investors, venture capital firms Khosla Ventures and Artis Capital Management, said they would buy up to 3.5 million shares at its listing price in the initial public offering, according to its regulatory filing.
Kior, a US-based biofuels developer backed by Netherlands-based Bioecon and which has former US Secretary of State Condoleezza Rice on its board, has raised $150m in Nasdaq flotation after pricing its shares below the forecast range at $15 each.
Kior sold 10 million shares below its $19 to $21 per share range and two of its investors, venture capital firms Khosla Ventures and Artis Capital Management, said they would buy up to 3.5 million shares at its listing price in…
